Synthesis and evaluation of a fluorine-18 labeled antisense oligonucleotide as a potential PET tracer for iNOS mRNA expression
- 31 July 2004
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 31 (5) , 605-612
- https://doi.org/10.1016/j.nucmedbio.2004.02.002
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-κB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosisJournal of Hepatology, 2002
- Antisense Oligodeoxynucleotide to Inducible Nitric Oxide Synthase Protects against Transient Focal Cerebral Ischemia—Induced Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2001
- Inhibition of Human Telomerase Activity by Antisense Phosphorothioate Oligonucleotides Encapsulated with the Transfection Reagent, FuGENE™6, in HeLa CellsAntisense and Nucleic Acid Drug Development, 2000
- Differential regulation of IFN‐γ, IL‐10 and inducible nitric oxide synthase in human T cells by cyclic AMP‐dependent signal transduction pathwayImmunology, 1997
- Alternative Splicing of Human Inducible Nitric-Oxide Synthase mRNAJournal of Biological Chemistry, 1996
- In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia.Journal of Clinical Investigation, 1996
- Progress in Antisense Oligonucleotide TherapeuticsAnnual Review of Pharmacology and Toxicology, 1996
- Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.Journal of Clinical Investigation, 1995
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Therapeutic Applications of OligonucleotidesAnnual Review of Pharmacology and Toxicology, 1992